Medeloop
Private Company
Total funding raised: $4.3M
Overview
Medeloop is a San Francisco-based digital health and AI company founded in 2020, offering a no-code platform that automates and accelerates clinical and public health research. Its core technology consists of specialized AI agents that assist with data analytics, study management, and grant proposal generation, targeting inefficiencies in traditional research workflows. The company serves life sciences and healthcare organizations, positioning itself as a tool to democratize research, ensure compliance, and reduce analysis time from months to minutes. As a private, early-stage company, Medeloop is focused on platform adoption and scaling its commercial operations.
Technology Platform
End-to-end, no-code AI platform featuring specialized 'AI agents' for data analytics (Analytics Genius), study management (Studies Genius), and grant writing/funding matching (Grants Genius). Designed to securely handle healthcare data and automate research workflows.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Medeloop competes in a fragmented landscape including large clinical trial software suites (e.g., Veeva Vault, Medidata Rave), standalone data analytics platforms (e.g., SAS, Palantir), and a growing number of AI-native life sciences startups. Its differentiation lies in its integrated, end-to-end approach combining analytics, study ops, and grants, all through a no-code interface powered by conversational AI agents.